A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
- Status
- TERMINATED
- Phase
- PHASE3
Related studies linked through entity extraction aliases.